Back to Search
Start Over
Immunome, Morphimmune reverse merge, with ex-Seagen CEO Clay Siegall to lead a year after domestic abuse arrest.
- Source :
- FierceBiotech; 6/29/2023, pN.PAG-N.PAG, 1p
- Publication Year :
- 2023
-
Abstract
- Immunome and Morphimmune will merge, with Seagen's former CEO in the chief executive chair a year after his domestic abuse arrest. [ABSTRACT FROM AUTHOR]
- Subjects :
- DOMESTIC violence
CHIEF executive officers
ARREST
MERGERS & acquisitions
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 164690633